神經再生療法市場：按神經再生療法類型、適應症、給藥方法、年齡層、最終用戶和地區分類

神經再生治療市場在2025年估計為147.7億美元，預計到2032年將達到336.9億美元，2025年至2032年的年複合成長率（CAGR）為12.5%。

神經再生是指神經組織（包括神經元、軸突、突觸和神經膠質細胞）再生或修復的過程。這個過程對於修復因損傷而受損的組織並確保長期功能恢復至關重要。新的神經細胞和神經連接被合成，為受損神經細胞的替換提供新的資源。神經再生不僅是身體復健的重要機制，也是維持認知功能的重要機制。它在對抗記憶力障礙和與老齡化相關的異常方面發揮關鍵作用。神經再生的藥物刺激可以恢復認知功能，並改善記憶力和其他認知能力。簡而言之，神經再生是一個關鍵的生物學過程，對治療各種神經系統疾病和促進大腦健康具有重要意義。

市場動態：

預計全球神經再生療法市場在未來幾年將顯著成長，這主要得益於以下幾個關鍵因素。首先，包括中樞和周邊神經系統疾病在內的神經系統疾病盛行率不斷上升，對有效安全的治療方法的需求也隨之增加。這些疾病會對患者的生活造成嚴重影響，因此神經再生療法至關重要。其次，全球老化人口正在快速成長。老年人更容易患神經系統疾病，這進一步增加了對此類治療方法的需求。隨著人們尋求改善生活品質的治療方法，神經再生療法市場預計將擴大。最後，神經再生領域的研發活動激增。科學家和研究人員不斷探索新的治療方法，並在如何刺激神經組織修復和再生方面取得突破。這種持續的創新預計將為市場帶來新的治療方法，進一步推動成長。摘要，高疾病負擔、人口老化以及積極的研發將推動全球神經再生療法市場向前發展。

例如，2023年2月6日，生物技術公司Biogen Inc.和Sage Therapeutics, Inc.宣布，美國食品藥物管理局(FDA)已接受新藥認證用於治療重度憂鬱症(MDD)和產後憂鬱症(PPD)的Zuranolone新藥申請(NDA)。 Zuranolone是一種在臨床實驗藥物，目前正在評估其作為每日一次、14天速效口服藥物，用於治療MDD和PPD成年患者。

本研究的主要特點

• 本報告對全球神經再生治療市場進行了詳細分析，並以 2024 年為基準年，展示了預測期 2025 年至 2032 年的市場規模和年複合成長率。
• 它還強調了各個領域的潛在商機，並說明了該市場的有吸引力的投資提案矩陣。
• 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的主要考察。
• 該報告涵蓋了全球神經再生療法市場的主要企業概況，基於以下參數，例如公司亮點、產品系列、主要亮點、財務表現和策略。
• 本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
• 全球神經再生療法市場報告迎合了該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
• 相關人員將透過用於分析全球神經再生療法市場的各種策略矩陣更輕鬆地做出決策。

目錄

第1章 調查目的與前提條件

• 研究目標
• 先決條件
• 簡稱

第2章 市場展望

• 報告描述
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map（COM）

第3章市場動態、法規與趨勢分析

• 市場動態
  • 神經系統疾病負擔日益加重
  • 成本高且專業技術人員短缺
  • 安全有效治療的需求很高
• 影響分析
• 主要亮點
• 監管情景
• 產品發布/核准
• PEST分析
• 波特分析
• 併購場景

第4章全球神經再生療法市場-冠狀病毒（COVID-19）大流行的影響

• COVID-19流行病學
• 供需側分析
• 經濟影響

5. 全球神經再生療法市場（依神經再生療法類型分類），2020 年至 2032 年

• 幹細胞療法
• 基因治療
• 藥物治療
• 神經刺激療法
• 其他

6. 2020 年至 2032 年全球神經再生療法市場（依適應症分類）

• 脊髓損傷
• 中風
• 創傷性腦損傷
• 帕金森氏症
• 阿茲海默症
• 多發性硬化症
• 周邊神經損傷
• 其他

7. 全球神經再生療法市場（以交付方式），2020 年至 2032 年

• 口服
• 注射
• 嵌入式
• 其他

8. 全球神經再生療法市場（依年齡層分類），2020 年至 2032 年

• 孩子們
• 成人
• 老年人

9. 全球神經再生療法市場（按最終用戶分類），2020 年至 2032 年

• 醫院
• 專科診所
• 研究所
• 復健中心
• 其他

第 10 章。 2020 年至 2032 年按地區分類的全球神經再生治療市場

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 西班牙
  • 法國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • ASEAN
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
• 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東地區
• 非洲
  • 南非
  • 北非
  • 中部非洲

第11章競爭格局

• Biogen Inc.
• AstraZeneca PLC
• Pfizer Inc.
• Novartis International AG
• Merck & Co., Inc.
• Sanofi SA
• F. Hoffmann-La Roche Ltd.
• Medtronic plc
• Boston Scientific Corporation
• Abbott Laboratories
• Ceregene Inc.
• Lineage Cell Therapeutics, Inc.
• Stemedica Cell Technologies, Inc.
• StemCells Inc.
• Ever Supreme Bio Technology Co., Ltd.
• AbbVie

第12章 章節

• 調查方法
• 關於出版商

Neuroregeneration Therapy Market is estimated to be valued at USD 14.77 Bn in 2025 and is expected to reach USD 33.69 Bn by 2032, growing at a compound annual growth rate (CAGR) of 12.5% from 2025 to 2032.

Neuroregeneration refers to the process of regenerating or repairing nervous tissue, including neurons, axons, synapses, and glial cells. This process is crucial for replacing damaged tissues due to injury and ensuring long-term functional recovery. It involves the synthesis of new neurons and connections, providing additional resources to substitute the damaged ones. Neuroregeneration is not just about physical recovery; it's also a vital mechanism for maintaining cognitive functions. It plays a significant role in combating memory disorders and abnormalities related to aging. By pharmacologically stimulating neuroregeneration, it's possible to rescue cognitive functions, thereby improving memory and other cognitive abilities. In essence, neuroregeneration is a critical biological process with significant implications for treating various neurological conditions and improving brain health.

Market Dynamics:

The global neuroregeneration therapy market is expected to witness significant growth in the coming years, driven by several key factors. Firstly, the increasing prevalence of neurological disorders, including both central and peripheral nervous system disorders, is creating a high demand for effective and safe treatments. These disorders can have a debilitating impact on patients' lives, making the need for neuroregenerative therapies crucial. Secondly, the world's aging population is growing rapidly. Older individuals are more susceptible to neurological conditions, which further increases the demand for these therapies. As people seek treatments that can improve their quality of life, the market for neuroregeneration therapies is expected to expand. Lastly, there is a surge in research and development activities in the field of neuroregeneration. Scientists and researchers are continually exploring new treatment methods and making breakthroughs in understanding how to stimulate the repair and regrowth of nervous tissue. This ongoing innovation is expected to introduce new therapies to the market, driving further growth. In summary, the combination of a high disease burden, an aging population, and active research and development are set to propel the global neuroregeneration therapy market forward.

For instance, on February 6, 2023, Biogen Inc., a biotechnology company, and Sage Therapeutics, Inc., a biotechnology company, announced that the U.S. Food and Drug Administration (FDA) had accepted the filing of a New Drug Application (NDA) for zuranolone in the treatment of major depressive disorder (MDD) and postpartum depression (PPD). Zuranolone is an investigational drug being evaluated as a 14-day, rapid-acting, once-daily, oral treatment in adults with MDD and PPD.

Key features of the study:

• This report provides in-depth analysis of the global neuroregeneration therapy market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global neuroregeneration therapy market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Biogen Inc., AstraZeneca PLC, Pfizer Inc., Novartis International AG, Merck & Co., Inc., Sanofi S.A., F. Hoffmann-La Roche Ltd., Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Ceregene Inc., Stemedica Cell Technologies, Inc., Lineage Cell Therapeutics, Inc., StemCells Inc., Ever Supreme Bio Technology Co., Ltd. and AbbVie
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global neuroregeneration therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global neuroregeneration therapy market

Detailed Segmentation:

• By Type of Neuroregeneration Therapy:
  • Stem Cell Therapy
  • Gene Therapy
  • Pharmacological Therapy
  • Neurostimulation Therapy
  • Others
• By Indication:
  • Spinal Cord Injury
  • Stroke
  • Traumatic Brain Injury
  • Parkinson's Disease
  • Alzheimer's Disease
  • Multiple Sclerosis
  • Peripheral Nerve Injury
  • Others
• By Mode of Administration:
  • Oral
  • Injectable
  • Implantable
  • Others
• By Age Group:
  • Pediatric
  • Adult
  • Geriatric
• By End User:
  • Hospitals
  • Specialty Clinics
  • Research Institutes
  • Rehabilitation Centers
  • Others
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Biogen Inc.
  • AstraZeneca PLC
  • Pfizer Inc.
  • Novartis International AG
  • Merck & Co., Inc.
  • Sanofi S.A.
  • F.Hoffmann-La Roche Ltd.
  • Medtronic plc
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Ceregene Inc.
  • Lineage Cell Therapeutics, Inc.
  • Stemedica Cell Technologies, Inc.
  • StemCells Inc.
  • Ever Supreme Bio Technology Co., Ltd.
  • AbbVie

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Type of Neuroregeneration Therapy
  • Market Snippet, By Indication
  • Market Snippet, By Mode of Administration
  • Market Snippet, By Age Group
  • Market Snippet, By End User
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Growing burden of neurological disorders
  • High cost and dearth of skilled professionals
  • High demand for safe and effective therapeutics
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Neuroregeneration Therapy Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Neuroregeneration Therapy Market, By Type of Neuroregeneration Therapy, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Stem Cell Therapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Gene Therapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Pharmacological Therapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Neurostimulation Therapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

6. Global Neuroregeneration Therapy Market, By Indication, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Spinal Cord Injury
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Stroke
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Traumatic Brain Injury
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,( US$ Bn)
• Parkinson's Disease
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Alzheimer's Disease
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Multiple Sclerosis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032 ,(US$ Bn)
• Peripheral Nerve Injury
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

7. Global Neuroregeneration Therapy Market, By Mode of Administration, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Oral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Injectable
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Implantable
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Other
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

8. Global Neuroregeneration Therapy Market, By Age Group, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Pediatric
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Adult
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Geriatric
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

9. Global Neuroregeneration Therapy Market, By End User, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Specialty Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Rehabilitation Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

10. Global Neuroregeneration Therapy Market, By Region, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type of Neuroregeneration Therapy, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type of Neuroregeneration Therapy, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type of Neuroregeneration Therapy, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type of Neuroregeneration Therapy, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type of Neuroregeneration Therapy, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type of Neuroregeneration Therapy, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Bn)
    • South Africa
    • North Africa
    • Central Africa

11. Competitive Landscape

• Biogen Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• AstraZeneca PLC
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Pfizer Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Novartis International AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Merck & Co., Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Sanofi S.A.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• F. Hoffmann-La Roche Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Medtronic plc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Boston Scientific Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Abbott Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Ceregene Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Lineage Cell Therapeutics, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Stemedica Cell Technologies, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• StemCells Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Ever Supreme Bio Technology Co., Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• AbbVie
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Analyst Views

12. Section

• Research Methodology
• About us